Focus: Spryte Medical is a neuro-intravascular imaging agent biotech company focused on endovascular treatment solutions for intracranial aneurysms. The company is early-stage with a single clinical trial (INSYTE) recently completing enrollment.
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Stable — net +1 jobs in 30d
4 added, 3 removed. Backfill posture.
Spryte Medical is a high-risk, early-stage play best suited for mission-driven professionals willing to trade stability for deep technical ownership in a niche neuro-intervention space.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Spryte Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Spryte Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Spryte Medical completes enrolment in INSYTE trial - NeuroNews International
Spryte Medical completes enrolment in INSYTE trial NeuroNews International
OKYO Pharma Announces Purchase of Shares by Chairman - The Manila Times
OKYO Pharma Announces Purchase of Shares by Chairman The Manila Times
Spryte Medical Completes INSYTE Trial Enrollment - GlobeNewswire
Spryte Medical Completes INSYTE Trial Enrollment GlobeNewswire
Spryte Medical Completes INSYTE Trial Enrollment - Yahoo Finance
Spryte Medical Completes INSYTE Trial Enrollment Yahoo Finance
Spryte Medical Announces First Participants Enrolled in the INSYTE Trial at Baptist Health Jacksonville - Yahoo Finance
Spryte Medical Announces First Participants Enrolled in the INSYTE Trial at Baptist Health Jacksonville Yahoo Finance
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 8 publications